Citadel Advisors’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Buy |
843,300
+50,200
| +6% | +$820K | ﹤0.01% | 2943 |
|
|
2025
Q4 | $10.2M | Buy |
793,100
+1,000
| +0.1% | +$10.6K | ﹤0.01% | 3230 |
|
|
2025
Q3 | $6.69M | Sell |
792,100
-52,100
| -6% | -$491K | ﹤0.01% | 3856 |
|
|
2025
Q2 | $7.28M | Buy |
844,200
+692,100
| +455% | +$5.14M | ﹤0.01% | 3492 |
|
|
2025
Q1 | $1.31M | Buy |
152,100
+51,500
| +51% | +$366K | ﹤0.01% | 6350 |
|
|
2024
Q4 | $673K | Buy |
100,600
+20,500
| +26% | +$152K | ﹤0.01% | 7907 |
|
|
2024
Q3 | $576K | Sell |
80,100
-165,700
| -67% | -$1.53M | ﹤0.01% | 7963 |
|
|
2024
Q2 | $2.55M | Buy |
245,800
+159,600
| +185% | +$1.59M | ﹤0.01% | 4864 |
|
|
2024
Q1 | $866K | Sell |
86,200
-192,300
| -69% | -$2.07M | ﹤0.01% | 7226 |
|
|
2023
Q4 | $4.25M | Sell |
278,500
-199,700
| -42% | -$2.76M | ﹤0.01% | 4047 |
|
|
2023
Q3 | $6.69M | Buy |
478,200
+278,600
| +140% | +$4.21M | ﹤0.01% | 3227 |
|
|
2023
Q2 | $2.64M | Sell |
199,600
-18,700
| -9% | -$254K | ﹤0.01% | 4672 |
|
|
2023
Q1 | $3.51M | Sell |
218,300
-60,200
| -22% | -$1.06M | ﹤0.01% | 4386 |
|
|
2022
Q4 | $4.14M | Buy |
278,500
+40,800
| +17% | +$710K | ﹤0.01% | 4185 |
|
|
2022
Q3 | $4.73M | Buy |
237,700
+18,400
| +8% | +$456K | ﹤0.01% | 3967 |
|
|
2022
Q2 | $4.49M | Buy |
219,300
+36,500
| +20% | +$902K | ﹤0.01% | 4009 |
|
|
2022
Q1 | $5.55M | Sell |
182,800
-75,500
| -29% | -$2.95M | ﹤0.01% | 3977 |
|
|
2021
Q4 | $10.6M | Buy |
258,300
+5,300
| +2% | +$221K | ﹤0.01% | 2989 |
|
|
2021
Q3 | $10.7M | Buy |
253,000
+65,800
| +35% | +$3.25M | ﹤0.01% | 2959 |
|
|
2021
Q2 | $9.87M | Buy |
187,200
+122,500
| +189% | +$6.09M | ﹤0.01% | 3094 |
|
|
2021
Q1 | $2.87M | Sell |
64,700
-8,800
| -12% | -$434K | ﹤0.01% | 5548 |
|
|
2020
Q4 | $3.53M | Buy |
73,500
+10,100
| +16% | +$487K | ﹤0.01% | 4302 |
|
|
2020
Q3 | $2.96M | Sell |
63,400
-50,300
| -44% | -$2.47M | ﹤0.01% | 4014 |
|
|
2020
Q2 | $5.11M | Sell |
113,700
-19,800
| -15% | -$769K | ﹤0.01% | 3057 |
|
|
2020
Q1 | $3.89M | Buy |
133,500
+30,500
| +30% | +$1.14M | ﹤0.01% | 3070 |
|
|
2019
Q4 | $4.91M | Sell |
103,000
-39,300
| -28% | -$1.7M | ﹤0.01% | 3101 |
|
|
2019
Q3 | $5.39M | Sell |
142,300
-57,900
| -29% | -$2.26M | ﹤0.01% | 3009 |
|
|
2019
Q2 | $8.56M | Sell |
200,200
-123,900
| -38% | -$5.87M | ﹤0.01% | 2362 |
|
|
2019
Q1 | $17.2M | Sell |
324,100
-268,400
| -45% | -$15.4M | 0.01% | 1487 |
|
|
2018
Q4 | $34.9M | Buy |
592,500
+373,500
| +171% | +$20.6M | 0.02% | 824 |
|
|
2018
Q3 | $11.9M | Sell |
219,000
-4,400
| -2% | -$243K | 0.01% | 1910 |
|
|
2018
Q2 | $12M | Sell |
223,400
-147,600
| -40% | -$7.76M | 0.01% | 1759 |
|
|
2018
Q1 | $18.1M | Sell |
371,000
-183,000
| -33% | -$7.77M | 0.01% | 1201 |
|
|
2017
Q4 | $18.8M | Sell |
554,000
-4,200
| -0.8% | -$147K | 0.01% | 1196 |
|
|
2017
Q3 | $18.9M | Sell |
558,200
-9,000
| -2% | -$308K | 0.01% | 1100 |
|
|
2017
Q2 | $20.2M | Buy |
567,200
+12,400
| +2% | +$418K | 0.02% | 993 |
|
|
2017
Q1 | $16.1M | Sell |
554,800
-225,200
| -29% | -$6.26M | 0.01% | 1105 |
|
|
2016
Q4 | $18.8M | Buy |
780,000
+205,000
| +36% | +$5.6M | 0.02% | 924 |
|
|
2016
Q3 | $17.8M | Buy |
575,000
+57,000
| +11% | +$1.8M | 0.02% | 932 |
|
|
2016
Q2 | $15.2M | Sell |
518,000
-9,800
| -2% | -$293K | 0.02% | 955 |
|
|
2016
Q1 | $16.2M | Buy |
527,800
+19,800
| +4% | +$511K | 0.02% | 875 |
|
|
2015
Q4 | $13.6M | Buy |
508,000
+34,400
| +7% | +$956K | 0.01% | 1061 |
|
|
2015
Q3 | $12.9M | Sell |
473,600
-131,400
| -22% | -$3.6M | 0.01% | 1177 |
|
|
2015
Q2 | $16.7M | Sell |
605,000
-460,800
| -43% | -$11.2M | 0.01% | 1127 |
|
|
2015
Q1 | $22.8M | Sell |
1,065,800
-148,800
| -12% | -$2.54M | 0.02% | 910 |
|
|
2014
Q4 | $22.9M | Buy |
1,214,600
+107,600
| +10% | +$2.3M | 0.02% | 841 |
|
|
2014
Q3 | $24.2M | Buy |
1,107,000
+729,000
| +193% | +$19.5M | 0.03% | 801 |
|
|
2014
Q2 | $12.2M | Sell |
378,000
-293,200
| -44% | -$8.99M | 0.01% | 1115 |
|
|
2014
Q1 | $19.2M | Sell |
671,200
-346,200
| -34% | -$11.4M | 0.02% | 848 |
|
|
2013
Q4 | $40M | Sell |
1,017,400
-810,200
| -44% | -$28.1M | 0.05% | 443 |
|
|
2013
Q3 | $63.8M | Buy |
1,827,600
+1,457,400
| +394% | +$45.1M | 0.1% | 221 |
|
|
2013
Q2 | $8.36M | Buy |
+370,200
| New | +$7.88M | 0.01% | 1186 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
Citadel Advisors's HLF Position: Q1 2026 in Review
Citadel Advisors reduced its Herbalife (HLF) stake by 34% in Q1 2026, selling an estimated $1.83M and leaving 214,320 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5171.
Citadel Advisors first reported a position in HLF in Q2 2013 and has held it in 48 quarters since. The position peaked at $29.3M in Q2 2015. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- Citadel Advisors held 214,320 shares of Herbalife worth $3.15M as of Q1 2026.
- Citadel Advisors sold 111,984 Herbalife shares in Q1 2026, an estimated $1.83M.
- Herbalife made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5171 holding.
- Citadel Advisors first reported a position in Herbalife in Q2 2013 and has held it in 48 quarters since.
- Citadel Advisors's Herbalife position peaked at $29.3M in Q2 2015.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.